We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An advisory panel has recommended against FDA approval for Medtronic's Chronicle implantable hemodynamic monitor system until the firm can conduct a larger clinical trial.
In a letter published in the Feb. 15 issue of the New England Journal of Medicine, molecular pathologist and attorney Roger Klein of the Yale University School of Medicine questioned the validity of patents used to prevent clinical laboratories from performing certain genetic tests.
St. Jude Medical announced the first patient has been implanted in a pilot study that will preliminarily evaluate if stimulating nerves near the spinal cord will control chronic chest pain caused by angina.
Boston Scientific recently announced the launch of its "Race Against Pain" public awareness campaign to promote its new generation of spinal cord stimulation (SCS) therapy, the Precision multi-SCS system.
Women who take estrogen as hormone replacement therapy to counter the effects of menopause may be better off using a transdermal patch than swallowing a pill, according to a recent study.
Becton Dickinson's (BD) unit BD Biosciences and Swiss diagnostics firm Roche announced a new collaboration to improve the understanding of pathways that carry information inside cells and identify why those pathways can malfunction and cause disease.
Medtronic's implantable cardioverter-defibrillator (ICD) direct-to-consumer (DTC) ad campaign helps St. Jude Medical more than it helps Medtronic, according to Lazard Capital Markets.
A clinical investigator recently received an FDA warning letter for implanting his experimental devices in 175 subjects without the proper informed consent forms.